Your browser doesn't support javascript.
loading
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies.
Garrido-Cano, Iris; Adam-Artigues, Anna; Lameirinhas, Ana; Blandez, Juan F; Candela-Noguera, Vicente; Rojo, Federico; Zazo, Sandra; Madoz-Gúrpide, Juan; Lluch, Ana; Bermejo, Begoña; Sancenón, Felix; Cejalvo, Juan Miguel; Martínez-Máñez, Ramón; Eroles, Pilar.
Affiliation
  • Garrido-Cano I; Biomedical Research Institute INCLIVA, Valencia, 46010, Spain.
  • Adam-Artigues A; Bioengineering, Biomaterials and Nanomedicine Networking Biomedical Research Centre (CIBER-BBN), Madrid, 28029, Spain.
  • Lameirinhas A; Biomedical Research Institute INCLIVA, Valencia, 46010, Spain.
  • Blandez JF; Biomedical Research Institute INCLIVA, Valencia, 46010, Spain.
  • Candela-Noguera V; Bioengineering, Biomaterials and Nanomedicine Networking Biomedical Research Centre (CIBER-BBN), Madrid, 28029, Spain.
  • Rojo F; Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM), Polytechnic University of Valencia, University of Valencia, Valencia, 46010, Spain.
  • Zazo S; Joint Unit CIPF-UPV of Mechanisms of Diseases and Nanomedicine, Valencia, Polytechnic University of Valencia, Prince Felipe Research Center, Valencia, 46012, Spain.
  • Madoz-Gúrpide J; Joint Research Unit in Nanomedicine and Sensors, Polytechnic University of Valencia, Medical Research Institute Hospital La Fe, Valencia, 46026, Spain.
  • Lluch A; Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM), Polytechnic University of Valencia, University of Valencia, Valencia, 46010, Spain.
  • Bermejo B; Biomedical Research Networking Center in Oncology (CIBERONC), Madrid, 28029, Spain.
  • Sancenón F; Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute, Madrid, 28040, Spain.
  • Cejalvo JM; Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute, Madrid, 28040, Spain.
  • Martínez-Máñez R; Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute, Madrid, 28040, Spain.
  • Eroles P; Biomedical Research Institute INCLIVA, Valencia, 46010, Spain.
Cancer Commun (Lond) ; 42(12): 1412-1416, 2022 12.
Article in En | MEDLINE | ID: mdl-35997029
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Cancer Commun (Lond) Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Cancer Commun (Lond) Year: 2022 Document type: Article Affiliation country: